Just a month after taking up the CEO role at Legend Biotech, Frank Zhang has been forced to step aside by the board following an investigation into suspected illegal activity by Chinese customs.

Legend Biotech Corporation Sponsored ADR (LEGN) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most ...

SOMERSET, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the ...

To address this bottleneck, therapy production has expanded from Legend’s one manufacturing ... entities that receive federal funds from using biotechnology from a concern associated with ...

SOMERSET, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET ...

Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other ...

Through media analysis and arguments, this 10 minute video essay will explore the importance of fictional world building using combinations of found/recorded footage, accompanied by Frank’s narration.

On Tuesday, RBC Capital adjusted its outlook on Legend Biotech Corp. (NASDAQ: LEGN) shares, increasing the price target to $86 ...